| Patents for C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960) |
|---|
| 07/10/2008 | WO2008082725A1 Pyridazinone compounds |
| 07/10/2008 | WO2008082009A2 Fused substituted aminopyrrolidine derivative |
| 07/10/2008 | WO2008081860A1 Optically active succinic acid imide derivative, process for production thereof, and use thereof |
| 07/10/2008 | WO2008081012A1 Spiropiperidine derivatives as nk3 antagonists |
| 07/10/2008 | WO2008046232A8 Aziridine aldehydes, aziridine-conjugated amino derivatives, aziridine-conjugated biomolecules and processes for their preparation |
| 07/10/2008 | US20080167339 Hormone sensitive diseases; atherosclerosis; cardiovascular disorders; congestive heart failure; antidiabetic agents; metaboolism disorders; reducing triglycweride concentration |
| 07/10/2008 | US20080167299 menopause therapy; contraceptive; anticancer agents |
| 07/10/2008 | US20080167296 Aids therapy; viricides |
| 07/10/2008 | CA2674141A1 Spiropiperidine derivatives as nk3 antagonists |
| 07/09/2008 | EP1940845A1 Novel azetidine compounds useful in the treatment of functional gastrointestinal disorders, ibs and functional dyspepsia |
| 07/09/2008 | EP1940828A2 Heterocyclic aspartyl protease inhibitors |
| 07/09/2008 | EP1940810A2 Inhibitors of phosphodiesterase type-iv |
| 07/09/2008 | EP1940411A2 Macroheterocylic compounds as kinase inhibitors |
| 07/09/2008 | EP1940296A2 Chemical compounds |
| 07/09/2008 | CN101218236A 2-heterocyclyloxybenzoyl amino heterocyclyl compounds as modulators of glucokinase for the treatment of type 2 diabetes |
| 07/09/2008 | CN100400540C Isoxazoline derivatives as anti-depressants |
| 07/08/2008 | US7396932 Fusing a N-phenyl-C-leaving group-C-carbonyl- or oxycarbonylhydrazide with a 1-(p-nitrophhenyl)-3-halo-tetrahydro-2-piperidone; subsequent reactions include reduction and amidation of the nitro group and amidation of carbonyl or ester group; final products include factor Xa inhibitors |
| 07/08/2008 | CA2432131C Pyrazole compounds useful as protein kinase inhibitors |
| 07/03/2008 | WO2008078674A1 Glucokinase-activating substance |
| 07/03/2008 | WO2008077643A1 Process for the preparation of an antibacterial quinolone compound |
| 07/03/2008 | WO2008057511A3 Ascomycin and pimecrolimus having reduced levels of desmethylascomycin and 32-deoxy-32-epichloro-desmethylascomycin respectively, and methods for preparation thereof |
| 07/03/2008 | WO2008051493A3 Heteroaryl compounds, compositions thereof, and their use as protein kinase inhibitors |
| 07/03/2008 | US20080161341 Novel imidazothiazoles and imidazoxazoles |
| 07/03/2008 | US20080161334 Macrolides |
| 07/03/2008 | US20080161312 Derivatives of Pyrrolo-Pyrazines Having a Kinase Inhibitory Activity and Their Biological Applications |
| 07/03/2008 | US20080161301 2-Oxy-Benzoxazinone Derivatives for the Treatment of Obesity |
| 07/03/2008 | US20080161299 6'-Bromo-1-[(5-methoxy-3-methyl-1H-indol-2-yl)carbonyl]-1'H-spiro[piperidine-4,4'-quinolin]-2'(3'H)-one; vasopressin receptors antagonist; antidepressant, anxiolytic agent; inappropriate secretion of vasopressin, liver cirrhosis, nephrotic syndrome, obsessive compulsive disorder |
| 07/03/2008 | US20080159982 ethyl 2-(biphenyl-4-yl)-6-(tert-butoxycarbonylamino)-2-methoxy-8-(2-nitrophenylsulfonyl)-5,16-dioxo-1,2,3,5,6,7,10,11,13a,14,14a,15,16,16a-hexadecahydrocyclopropa[n]pyrrolo[2,1-c][1,4,8]triazacyclopentadecine-14a-carboxylate; viricide; synergistic with other active ingredients |
| 07/03/2008 | CA2672088A1 Glucokinase activator |
| 07/02/2008 | EP1939206A1 Process for the preparation of an antibacterial quinolone compound |
| 07/02/2008 | EP1939205A1 Tricyclic compound |
| 07/02/2008 | CN100398539C Synthesis of heteroaryl acetamides |
| 07/02/2008 | CN100398519C Tetracyclic benzamide derivatives and methods of use thereof |
| 07/01/2008 | USRE40418 Treatment of neoplasms with CCI-779/EKB-569 combination |
| 07/01/2008 | US7393952 for coating implantable medical devices; typically more stable and typically have an increased solubility that allows for better uptake |
| 07/01/2008 | US7393866 Anticholesterol agents; antilipemic agents; cardiovascular disorders; antiischemic agents; anticancer agents |
| 07/01/2008 | US7393858 Tetrahydropyran compounds as tachykinin antagonists |
| 06/26/2008 | US20080153790 Polymer coatings as carriers for the drug delivery of a derivative of a methoxyaminocarbonyloxy-rapamycin and another drug(s) such as an antiproliferative agent, anticoagulant, etc.; reduces restenosis in vasculature procedures; to a level of 0-25%; coronary/periferal stents; grafts ; balloons |
| 06/25/2008 | EP1935887A1 Heterocyclic substituted carbonyl derivatives and their use as dopamine D3 receptor ligands |
| 06/25/2008 | EP1730119B1 Imidazole compounds for the treatment of neurodegenerative disorders |
| 06/25/2008 | CN100396670C N-substituted tricyclic 3-aminopyrazoles as PDFG receptor inhibitors, its pharmaceutical composition and use |
| 06/24/2008 | US7390903 Thieno-pyridine derivatives as allosteric enhancers of the GABAB receptors |
| 06/24/2008 | US7390895 Rapamycin analogues; diabetes, acute or chronic rejection of an organ or tissue transplant, asthma, tumours, psoriasis, eczema, rheumatoid arthritis, fibrosis, and allergies |
| 06/24/2008 | US7390875 Method for binding, in solution, a peptide and a lipophilic vector and uses thereof |
| 06/24/2008 | US7390815 Pyrazole compounds useful as protein kinase inhibitors |
| 06/24/2008 | US7390803 N-(3,5-bis-trifluoromethyl-benzyl)-1-(2-tert-butoxycarbonyl-amino-thiazol-4-yl)-3-(N-methyl, N-tetrahydro-4H-pyran-4-ylamino]-cyclopentanecarbamide; monocyte chemoattractant protein (MCP) receptor antagonist; antiinflammatory agent; antiallergen; autoimmune diseases; rhinitis, dermatitis, asthma |
| 06/19/2008 | WO2008071981A1 Piperidines for the treatment of bacterial infections |
| 06/19/2008 | WO2008071961A1 2-quinolinone and 2-quinoxalinone- derivatives and their use as antibacterial agents |
| 06/19/2008 | WO2008071404A1 Epothilone analogues modified at positions c12-c13 as anticancer drugs |
| 06/19/2008 | WO2008049123A3 2,4-pyrimidinediamine derivatives as inhibitors of jak kinases for the treatment of autoimmune diseases |
| 06/19/2008 | US20080146812 Novel Oxabispidine Compounds And Their Use In The Treatment Of Cardiac Arrhythmias |
| 06/19/2008 | US20080146551 Antibacterial Agents |
| 06/19/2008 | US20080145334 Hepatitis c virus inhibitors |
| 06/19/2008 | CA2671485A1 2-quinolinone and 2-quinoxalinone- derivatives and their use as antibacterial agents |
| 06/19/2008 | CA2671336A1 Epothilone analogues modified at positions c12-c13 as anticancer drugs |
| 06/18/2008 | EP1932888A1 Labeling dye for biomolecule, labeling kit, and method for detecting biomolecule |
| 06/18/2008 | EP1931684A2 Oxazolidinone-quinolone hybrids as antibacterial compounds |
| 06/18/2008 | EP1931627A1 Amino-alkyl-amide derivatives as ccr3 receptor ligands |
| 06/18/2008 | CN101203521A Process for the preparation of N,N'-disubstituted oxabispidines |
| 06/18/2008 | CN101203520A Process for the preparation of 3,7-dihydroxy-1,5-diazacyclooctanes |
| 06/18/2008 | CN101200472A Method for preparing 3-amido-4-imino rifamycin S |
| 06/17/2008 | US7388096 Crystalline forms of a factor Xa inhibitor |
| 06/17/2008 | US7388027 sarcopenia,frailty or age-related functional decline; nonsteroidal, nontoxic; side effect reduction;2-Chloro-4-(7-hydroxy-1-methyl-3-oxo-5,6,7,7a-tetrahydro-3H-pyrrolizin-2-yl)-3-methylbenzonitrile |
| 06/17/2008 | US7388010 fused hexacyclic derivatives consist of pyrrolidine, indazolone, quuinoxalinone rings; cyclin-dependent kinase inhibitor with cell growth-inhibitory activity; anticarcinogenic and antiproliferative agent |
| 06/12/2008 | WO2008068569A2 Processes for the preparation of clopidogrel hydrochloride |
| 06/12/2008 | WO2008068265A1 Novel substituted diaza spiro pyridinone derivatives for use in mch-1 mediated diseases |
| 06/12/2008 | WO2008068159A1 Spiro-piperidine derivatives |
| 06/12/2008 | WO2008037888A3 Tetracyclic compounds, process for the preparation thereof pharmaceutical compositions comprising the same and use thereof as dopaminergic receptor ligands |
| 06/12/2008 | US20080139601 3-Cyano-Quinoline Derivatives With Antiproliferative Activity |
| 06/12/2008 | US20080139544 Modulators of CCR5(chemokine) receptors; lymphadenopathy associated and human T-cell leukemia/lymphoma viruses; AIDS infections; autoimmune diseases; antiinflammatory agents; derivatives of 1-oxa-3,8-diaza-spiro[4.5]decan-2-one and 1-oxa-3,9-diaza-spiro[5.5]undecan-2-one |
| 06/12/2008 | US20080139529 Nervous system, neurodegenerative, psychiatric, sexual, attention deficit, and psychological disorders; cognition activators, antidepressants, anxiolytic agents; alcoholism, drug abuse, traumas, strokes, epilepsy, schizophrenia, autism, and/or Alzheimer's disease treatment |
| 06/12/2008 | CA2671990A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 06/12/2008 | CA2670671A1 Spiro-piperidine derivatives |
| 06/12/2008 | CA2664112A1 Novel substituted diaza-spiro-pyridinone derivatives for use in mch-1 mediated diseases |
| 06/11/2008 | EP1930319A1 Proline derivatives and use thereof as drugs |
| 06/11/2008 | EP1928890A2 Phosphonated rifamycins and uses thereof for the prevention and treatment of bone and joint infections |
| 06/11/2008 | EP1928887A1 Methods of preparing quinolone analogs |
| 06/11/2008 | EP1928886A1 Pyridine derivatives and their use in the treatment of psychotic disorders |
| 06/11/2008 | EP1255739B1 3-aminoquinazolin-2,4-dione antibacterial agents |
| 06/11/2008 | EP1230235B1 Compounds with antibacterial and antiparasitic properties |
| 06/11/2008 | CN101198609A Aspartyl protease inhibitors |
| 06/11/2008 | CN101195599A 2-alkoxy-4-halo-6-alkylphenyl-substituted (hetero)cyclic ketoenols |
| 06/10/2008 | US7385063 Method for preparing imidazole derivatives |
| 06/10/2008 | US7385056 Directly hydrogenating a heteroaryl alpha-hydroxyacetamide in the presence of a strong acid, a halide and a catalyst; for example, the heteroaryl acetamide is zolpidem and the heteroaryl alpha-hydroxyacetamide is alpha-hydroxyzolpidem |
| 06/10/2008 | US7384965 Fused heterocyclic derivatives as PPAR modulators |
| 06/10/2008 | US7384955 N-[1-(cyclohexylmethyl)-2-[(4-ethoxyphenyl)methyl]-1H-pyrrolo[2,3-b]pyridin-5-yl]-2,2-dimethyl-propanamide; cannabinoid CB1/CB2 receptor agonists; analgesic; in therapy, in particular in the management of pain |
| 06/10/2008 | US7384953 Purification of rapamycin |
| 06/10/2008 | US7384937 Antiarthritic agents; multiple sclerosis ; organ rejection ; antidiabetic agents; inflammatory bowel disorders; antiischemic agents; skin disorders |
| 06/10/2008 | US7384929 N-aryl azaspiroalkene and azaspiroalkane compounds and methods of preparation and use thereof |
| 06/10/2008 | CA2322790C Granulatimide derivatives for use in cancer treatment |
| 06/05/2008 | WO2008065887A1 Process for producing o-alkylated rapamycin derivative, and o-alkylated rapamycin derivative |
| 06/05/2008 | WO2008045377A3 High-purity large-scale preparation of stannsoporfin |
| 06/05/2008 | US20080132565 Polycyclic Macrolactones |
| 06/05/2008 | US20080132530 polymorphic forms alpha , beta and gamma; for the oral or topical route; In case of invasive bacteria, it may be useful to use the most bioavailable polymorphic form, whereas in case of non-invasive pathogens it may be more appropriate to use the less adsorbed forms, since they are safer |
| 06/05/2008 | US20080132510 to modulate ligand binding to GABAA receptors; treatment of central nervous system (CNS) disorders; anxiety, depression, a sleep disorder, attention deficit disorder, Alzheimer's dementia or short-term memory loss |
| 06/05/2008 | US20080132504 2, 4-Pyrimidinediamines Useful In The Treatment Of Neoplastic Diseases, Inflammatory And Immune System Disorders |
| 06/05/2008 | US20080132483 Administering (3R,5S)-N-propanesulfonyl-7-chloro-5-(2,3-dimethoxyphenyl)-1-(3-hydroxy-2,2-dimethylpropyl)-1,2,3,5-tetrahydro-4,1-benzoxazepine-3-acetamide; cerebral infarction |
| 06/05/2008 | DE60129697T2 Kondensierte azepinderivate und ihre verwendung als antidiuretisches mittel Condensed azepine derivatives and their use as antidiuretic agent |
| 06/04/2008 | EP1926733A2 Tetracyclic indole derivatives as antiviral agents |
| 06/04/2008 | EP1611139B1 Methods of preparing olanzapine |